The reference site for Trimegestone

Trimegestone (INN) (brand names Ondeva, Totelle Sekvens (both in combination with estrogen)) is a steroidal progestin of the 19-norprogesterone group related to promegestone

WHAT IS Trimegestone?

Trimegestone is a novel norpregnane progestin hormone that is being developed, in combination with estradiol, for the treatment of menopausal symptoms.

Additionally, trimesgestone is also being developed to be used in combination with other compounds as an oral contraceptive.

Brand Name(s): Prozac; Sarafem

CAS nº: 54910-89-3

(floo ‘ox e teen)

Product Info

The sections below will provide you with more specific information and guidelines related to trimegestone and its correct use. Please read them carefully.

FDA Information

Trimegestone is still under clinical development and has not yet received approval from the US FDA.

Regulatory authorities in Sweden recently approved the first commercial product using trimegestone, an HRT product, Totelle Sekvens®Totelle® employs a cyclic regimen for hormone replacement with 14 days using 2 mg of 17 beta estradiol alone and 14 days in combination with 500 mcg of trimegestone. When Totelle Sekvens® is launched by Wyeth-Ayerst in Sweden later this year it will offer women effective relief from vasomotor symptoms associated with menopause, improved and predictable cycle control, and a better lipid profile in comparison to existing products.

Please visit the official site of the FDA for further information.

Why is this medication prescribed?

Trimegestone is a novel norpregnane progestin hormone that is being developed, in combination with estradiol, for the treatment of menopausal symptoms.

Additionally, trimesgestone is also being developed to be used in combination with other compounds as an oral contraceptive.

Following FDA approval, this section will include further information regarding its uses and mechanism of action.

Other uses for this medicine

Trimegestone has not been investigated for its use in areas other than those mentioned in the previous section.

This information will be updated once further clinical trials have been carried out and the medication has received approval for commercialization in the US.

Dosage and using this medicine

Clinical trials are still being developed with trimegestone, and the exact dosage of treatment has yet to be determined.

This information will be provided once trimegestone has received FDA approval and is made available on the market.

What special precautions should I follow?

BEFORE TAKING TRIMEGESTONE:

Trimegestone is under clinical development, and patient information on special precautions that should be followed when taking this medication are not yet available.

Therefore no special precautions are required as this medication will only be administered once clinical studies have concluded and has received commercial approval.

What should I do if I forget a dose?

Trimegestone is currently not available on the market, and information regarding a missed dosage procedure is yet to be defined.

This information will be included once it has received FDA approval.

What side effects can this medication cause?

The exact side effects caused by this medication have not been concluded as various clinical studies are currently in development.

Further information will be provided shortly.

What storage conditions are needed for this medicine?

Indications regarding storage conditions for trimegestone will be defined once this medication has been approved and is available on the market.

In case of an emergency/overdose

The symptoms of an overdose using trimegestone are not known as this medication is currently undergoing clinical studies.

However, in the case of a suspected overdose when using any form of medication, you should call your local poison control center on 1-800-222-1222, or the emergency services on 911 if the person has collapsed or is not breathing.

Product Images

PICTURES OF TRIMEGESTONE PILLS

Trimegestone is undergoing clinical trials, and no forms or images of this medication currently exist on the market.

Following its approval by the FDA, this section will provide you with images and specific information on the principal types of trimegestone that exist, including their respective brand name(s), strength, inscription codes, manufacturers and/or distributors.

 

Contact us

If you are interested to acquire this site, please contact us.